| 000 | 00987 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250518035450.0 | ||
| 264 | 0 | _c20200605 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1474-5488 | ||
| 024 | 7 |
_a10.1016/S1470-2045(19)30228-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGnant, Michael | |
| 245 | 0 | 0 |
_aDenosumab in early-stage breast cancer - Authors' reply. _h[electronic resource] |
| 260 |
_bThe Lancet. Oncology _c05 2019 |
||
| 300 |
_a236 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aBone Density Conservation Agents |
| 650 | 0 | 4 | _aBreast Neoplasms |
| 650 | 0 | 4 | _aDenosumab |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPostmenopause |
| 700 | 1 | _aPfeiler, Georg | |
| 700 | 1 | _aFrantal, Sophie | |
| 773 | 0 |
_tThe Lancet. Oncology _gvol. 20 _gno. 5 _gp. 236 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1470-2045(19)30228-1 _zAvailable from publisher's website |
| 999 |
_c29647107 _d29647107 |
||